市場調查報告書
商品編碼
1617088
2030 年溴苯市場預測:按產品類型、牌號、應用和地區分類的全球分析Bromobenzene Market Forecasts to 2030 - Global Analysis by Product Type (Phenylmagnesium Bromide, Bromobenzene Solutions, Alkyl Bromides, Aryl Bromides and Polybrominated Compounds), Grade, Application and By Geography |
根據Stratistics MRC預測,2024年全球溴苯市場規模將達12億美元,預計2030年將達到17億美元,預測期內複合年成長率為5.3%。
溴苯是一種有機化合物,化學式為C6H5Br,是一種無色液體,有刺激性氣味。有機合成中用作溶劑和試劑。溴苯是由苯與溴在催化劑存在下反應生成的。它是一種用途廣泛的化合物,用於各種化學反應,例如藥物和農藥的合成。
不斷發展的製藥業
溴苯是合成各種藥物化合物(包括活性成分和試劑)的重要中間體。擴大醫療基礎設施和增加全球研發投資正在增加對溴苯的需求。隨著慢性病盛行率的上升和新藥處方的推動,製藥業繼續推動溴苯的消費,特別是在已開發經濟體和新興經濟體。預計這一趨勢將在預測期內維持市場成長。
替代化學品
出於成本效益、可用性和環境友善等原因,具有類似應用的替代試劑和溶劑通常是首選。這些替代化學物質可以減少工業過程中對溴苯的依賴,特別是在成本敏感的市場。此外,有關化學品使用的嚴格規定限制了某些地區溴苯市場的成長,因為這進一步推動了向更安全替代品的轉變。
特種化學品的擴張
溴苯廣泛用於生產醫藥、農藥和聚合物等特殊化學品。隨著業界擴大尋求高性能、客製化的解決方案,溴苯在創新化學配方中找到了自己的位置。特種化學品產業的成長,特別是在投資先進製造和研發的地區,預計將在預測期內創造對溴苯的巨大需求。
原料成本波動
由於供需失衡、地緣政治問題或貿易限制而導致的價格波動可能會擾亂溴苯的生產和盈利。這種不確定性往往會影響製造商規劃長期策略的能力,進而影響他們對下游產品的定價能力。這一因素仍然是市場的關鍵挑戰,因為原料成本是整體生產成本的關鍵決定因素。
由於供應鏈中斷、工業活動減少和勞動力有限,COVID-19 大流行擾亂了溴苯市場。隨著大流行措施收緊,製藥業的需求部分抵消了這一下降。然而,一旦疫情過後產業復甦且生產水準恢復正常,在製藥和特種化學品產業需求增加的推動下,市場開始恢復動力。
苯基溴化鎂業務預計將在預測期內成為最大的業務
預計苯基溴化鎂細分市場將在預測期內主導市場。這一優勢歸因於其在化學合成中的廣泛應用,特別是在藥物和特種化學品中。苯基溴化鎂是一種重要試劑,廣泛用於格氏反應產生高價值化合物。對複雜有機合成和高純度試劑的需求不斷成長也推動了該領域的崛起。
預計醫藥級細分市場在預測期間內複合年成長率最高
在預測期內,由於藥品製造中對高純度化合物的需求不斷增加,預計藥品級細分市場將呈現最高成長率。醫藥級溴苯廣泛用作原料藥合成的中間體。全球對醫療保健進步的關注以及製藥業研發投資的增加正在推動該領域的成長。此外,對藥品生產高品質原料的嚴格規定進一步增加了對藥品級溴苯的需求。
預計北美地區將在預測期內主導市場。這得歸功於該地區完善的製藥和化學工業,以及對研發的大力投資。主要製造商的存在和強大的醫療基礎設施進一步推動了對溴苯的需求。此外,支持先進化學應用的法律規範也有助於北美市場的主導地位。
預計亞太地區在預測期內的複合年成長率最高。這一成長是由中國和印度等國家的快速工業化、藥品產量增加以及特種化學品市場不斷擴大所推動的。具有成本效益的原料的供應以及對開發先進製造能力的日益關注也進一步推動了該地區對溴苯的需求。
According to Stratistics MRC, the Global Bromobenzene Market is accounted for $1.2 billion in 2024 and is expected to reach $1.7 billion by 2030 growing at a CAGR of 5.3% during the forecast period. Bromobenzene is an organic compound with the chemical formula C6H5Br. It's a colorless liquid with a pungent odor. It's used as a solvent and a reagent in organic synthesis. Bromobenzene is produced by reacting benzene with bromine in the presence of a catalyst. It's a versatile compound used in various chemical reactions, including the synthesis of pharmaceuticals and agrochemicals.
Growing pharmaceutical industry
Bromobenzene serves as a critical intermediate in synthesizing various pharmaceutical compounds, including active ingredients and reagents. The expansion of healthcare infrastructure and increased R&D investment globally has escalated the demand for bromobenzene. With rising incidences of chronic diseases and the push for new drug formulations, the pharmaceutical sector continuously fuels the consumption of bromobenzene, especially in developed and emerging economies. This trend is expected to sustain market growth during the forecast period.
Substitute chemicals
Alternative reagents and solvents with similar applications are often preferred due to cost efficiency, availability, or environmental concerns. These substitutes can reduce dependency on bromobenzene in industrial processes, especially in cost-sensitive markets. Additionally, stringent regulations on chemical usage further encourage the shift towards safer alternatives, thereby limiting bromobenzene's market growth in certain regions.
Expanding of specialty chemicals
Bromobenzene is widely used in producing specialty chemicals for applications in pharmaceuticals, agrochemicals, and polymers. As industries increasingly require high-performance and tailored solutions, bromobenzene finds its place in innovative chemical formulations. Growth in the specialty chemicals sector, especially in regions investing in advanced manufacturing and R&D, is expected to create substantial demand for bromobenzene during the forecast period.
Cost fluctuation of raw materials
Price volatility due to supply-demand imbalances, geopolitical issues, or trade restrictions can disrupt the production and profitability of bromobenzene. This uncertainty often impacts manufacturers' ability to plan long-term strategies and affects the pricing dynamics of downstream products. As raw material costs are a significant determinant of overall production costs, this factor remains a critical challenge for the market.
The Covid-19 pandemic disrupted the bromobenzene market due to supply chain interruptions, reduced industrial activities, and limitations in workforce availability. The pharmaceutical industry's demand partially offset this decline as efforts to combat the pandemic intensified. However, as industries recovered post-pandemic and production levels normalized, the market began to regain momentum, driven by increasing demand from pharmaceuticals and specialty chemicals sectors.
The phenylmagnesium bromide segment is expected to be the largest during the forecast period
Over the forecasted timeframe, the phenylmagnesium bromide segment is anticipated to dominate the market. This dominance is attributed to its extensive applications in chemical synthesis, particularly in pharmaceuticals and specialty chemicals. Phenylmagnesium bromide, an essential reagent, is widely used in Grignard reactions for producing high-value compounds. The growing demand for complex organic synthesis and high-purity reagents further supports this segment's prominence.
The pharmaceutical grade segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceutical grade segment is predicted to witness the highest growth rate due to the increasing demand for high-purity compounds in drug manufacturing. Pharmaceutical-grade bromobenzene is extensively utilized as an intermediate in synthesizing active pharmaceutical ingredients. The global emphasis on healthcare advancements, coupled with rising R&D investments in the pharmaceutical sector, drives this segment's growth. Additionally, stringent regulations necessitating high-quality inputs in drug production further enhance the demand for pharmaceutical-grade bromobenzene.
During the estimation period, the North America region is anticipated to dominate the market. This is due to the region's well-established pharmaceutical and chemical industries, coupled with significant investments in R&D. The presence of key manufacturers and a robust healthcare infrastructure further drive bromobenzene demand. Additionally, regulatory frameworks supporting advanced chemical applications contribute to the market's dominance in North America.
During the forecast period, the Asia Pacific region is anticipated to register the highest CAGR. This growth is driven by rapid industrialization, increasing pharmaceutical production, and expanding specialty chemical markets in countries like China and India. The availability of cost-effective raw materials and a growing emphasis on developing advanced manufacturing capabilities further boost bromobenzene's demand in the region.
Key players in the market
Some of the key players in Bromobenzene Market include Hawks Chemical Co Ltd, Alfa Aesar, Merck KGaA, ExxonMobil Corporation, Sontara Organo Industries, Tokyo Chemical Industry Co., Ltd., Weifang Yonhop Chemical Co., Ltd., Shandong Henglian Chemical Co., Ltd., Heranba Industries Ltd., Shanghai Wescco Chemical Co., Ltd., ChemSampCo Inc., Aarti Industries Limited, Solvay S.A., Jiangsu Tianxin Chemical Co., Ltd., Arkema Group, Eastman Chemical Company, and Lanxess AG.
In October 2024, Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, Missouri, USA. This investment will triple existing capacity and enhance the company's contract development and manufacturing organization (CDMO) offering, reinforcing its commitment to clients and patients.
In May 2024, Arkema has agreed to acquire Dow's flexible packaging laminating adhesives business, one of the leading producers of adhesives for the flexible packaging market, generating annual sales of around US$250 million. The proposed acquisition will significantly expand Arkema's portfolio of solutions for flexible packaging, enabling the Group to become a key player in this attractive market.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.